Michael Carrick addressed the press this afternoon ahead of Manchester United’s clash with Fulham on Sunday. His men are undergoing their final preparations ahead of his third match in charge, during ...
Winter Garden, FL, January 23rd, 2026, FinanceWireRobert J. Smith, MFA, a business consultant with over five decades of exper… Winter Garden, FL, January 23rd, 2026, FinanceWire Robert J. Smith,...
Cybersecurity specialist NCC Group said on Wednesday it has agreed to sell its Escode business to private equity firm TDR Capital for an enterprise value of 275 million pounds($369.35 million), leavin...
Proposed Combined Company Will be a Cash-Generating, AI-Focused Digital Infrastructure Platform AI-Ready Data Centers, Low-Cost Power and Strategic U.S…. Proposed Combined Company Will be a Cash...
Charles River Laboratories Provides Business Updates WILMINGTON, Mass.–(BUSINESS WIRE)–Charles River Laboratories International, Inc. (NYSE: CRL) today announced two planned acquisitions o...
– Reports $156 to $160 Million in Preliminary* Full-Year 2025 U.S. Net Product Sales, a 35% to 38% Increase Compared With Full-Year 2024 – –Total… – Reports $156 to $160 Million in Preliminary* ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced business and program updates ahead of upcoming investor meetings in January, including the… BOSTON–(BUSINESS WIRE)–...
IDEAYA Biosciences (IDYA) provided a business update including an overview of key corporate objectives for 2026. 2026 Corporate Objectives: Daro… IDEAYA Biosciences (IDYA) provided a business up...
Preliminary 4Q 2025 VYJUVEK net revenue of $106 million to $107 million Robust clinical pipeline with multibillion dollar opportunities and strong balance… Preliminary 4Q 2025 VYJUVEK net revenu...
– Rapidly transforming into a leading global biopharma company… COPENHAGEN, Denmark, Jan. 09, 2026 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today provided a business and...
